Back to Agenda
Regulatory Affairs: Part 5: The NDA – New Drug Application
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
Regulatory Affairs: Part 5: The NDA – New Drug Application
Have an account?